GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cadence Pharmaceuticals, Inc. (FRA:QEW) » Definitions » Days Inventory

Cadence Pharmaceuticals, (FRA:QEW) Days Inventory : 58.83 (As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Cadence Pharmaceuticals, Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Cadence Pharmaceuticals,'s Average Total Inventories for the three months ended in Dec. 2013 was €5.44 Mil. Cadence Pharmaceuticals,'s Cost of Goods Sold for the three months ended in Dec. 2013 was €8.43 Mil. Hence, Cadence Pharmaceuticals,'s Days Inventory for the three months ended in Dec. 2013 was 58.83.

The historical rank and industry rank for Cadence Pharmaceuticals,'s Days Inventory or its related term are showing as below:

FRA:QEW's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 199.78
* Ranked among companies with meaningful Days Inventory only.

Cadence Pharmaceuticals,'s Days Inventory declined from Dec. 2012 (72.84) to Dec. 2013 (58.83).

Inventory Turnover measures how fast the company turns over its inventory within a year. Cadence Pharmaceuticals,'s Inventory Turnover for the three months ended in Dec. 2013 was 1.55.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cadence Pharmaceuticals,'s Inventory-to-Revenue for the three months ended in Dec. 2013 was 0.21.


Cadence Pharmaceuticals, Days Inventory Historical Data

The historical data trend for Cadence Pharmaceuticals,'s Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cadence Pharmaceuticals, Days Inventory Chart

Cadence Pharmaceuticals, Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 27.52 61.85 74.15

Cadence Pharmaceuticals, Quarterly Data
Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.84 69.82 74.33 61.86 58.83

Competitive Comparison of Cadence Pharmaceuticals,'s Days Inventory

For the Biotechnology subindustry, Cadence Pharmaceuticals,'s Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cadence Pharmaceuticals,'s Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cadence Pharmaceuticals,'s Days Inventory distribution charts can be found below:

* The bar in red indicates where Cadence Pharmaceuticals,'s Days Inventory falls into.



Cadence Pharmaceuticals, Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cadence Pharmaceuticals,'s Days Inventory for the fiscal year that ended in Dec. 2013 is calculated as

Days Inventory (A: Dec. 2013 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2012 ) + Total Inventories (A: Dec. 2013 )) / count ) / Cost of Goods Sold (A: Dec. 2013 )*Days in Period
=( (4.951 + 6.312) / 2 ) / 27.72*365
=5.6315 / 27.72*365
=74.15

Cadence Pharmaceuticals,'s Days Inventory for the quarter that ended in Dec. 2013 is calculated as:

Days Inventory (Q: Dec. 2013 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Sep. 2013 ) + Total Inventories (Q: Dec. 2013 )) / count ) / Cost of Goods Sold (Q: Dec. 2013 )*Days in Period
=( (4.558 + 6.312) / 2 ) / 8.43*365 / 4
=5.435 / 8.43*365 / 4
=58.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cadence Pharmaceuticals,  (FRA:QEW) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cadence Pharmaceuticals,'s Inventory Turnover for the three months ended in Dec. 2013 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cadence Pharmaceuticals,'s Inventory to Revenue for the three months ended in Dec. 2013 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Cadence Pharmaceuticals, Days Inventory Related Terms

Thank you for viewing the detailed overview of Cadence Pharmaceuticals,'s Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Cadence Pharmaceuticals, Business Description

Traded in Other Exchanges
N/A
Address
Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing product candidates mainly for use in the hospital setting. The Company's main activities are conducting research and development activities as well as conducting clinical trials. The company has in-licensed rights to products: Acetavance, an intravenous formulation of acetaminophen, and Omigard, an omiganan pentahydrochloride 1% aqueous gel. It in-licensed the exclusive United States, or U.S., and Canadian rights to Acetavance from Bristol-Myers Squibb Company, or BMS, which markets this product candidate in Europe and other markets for the treatment of acute pain and fever under the brand name Perfalgan. The Company is developing Acetavance, a proprietary intravenous formulation of acetaminophen, for the U.S. market for the treatment of acute pain and fever in adults and children. In its oral form, acetaminophen is the most widely used drug for the treatment of pain and fever in the U.S. The Company's licensor, BMS, currently markets this proprietary intravenous formulation of acetaminophen for the treatment of acute pain and fever in Europe and several other markets outside the U.S, where it is known as paracetamol and is marketed under the brand name Perfalgan.

Cadence Pharmaceuticals, Headlines

No Headlines